|[January 20, 2014]
NextPharma Continues to Strengthen Its Business with Three Senior Appointments
LONDON --(Business Wire)--
NextPharma Technologies Holding Limited, a leading provider of contract
development and commercial manufacturing services to the global
pharmaceutical industry, today announced the appointment of two new Site
Managers and a group VP Quality and Regulatory.
Eric Bertrand assumes full leadership responsibility for the NextPharma
Centre of Excellence for Liquids in Limay, France. Eric's experience in
site management stretches over 17 years including FDA site management
for B. Braun. Eric has an impressive record in maximising site potential
and contributing to strong growth.
Ralf Blesel also assumes full leadership responsibility at the
NextPharma Centre of Excellence for Penicillins in Berlin, Germany. Ralf
has over thirty years' experience in the pharmaceutical industry
including nine years with Bayer and senior roles within contract
In addition, Nigel Cryer will be joining NextPharma as VP Quality and
Regulatory from April 1st 2014, assuming functional
leadership for the NextPharma Quality function. Nigel hasextensive
international experience leading quality teams and successfully
completing inspections with the FDA and other regulatory agencies.
"I am extremely pleased to be formally welcoming Eric, Ralf and Nigel
to the NextPharma team Andrew Kelley, NextPharma's Chief Operating
Officer, commented. I know that each of them will bring a remarkable
wealth of industry and leadership experience to their respective roles."
Franck Latrille, NextPharma's Chief Executive Officer, also stated: "I
am confident that NextPharma and its customers will significantly
benefit from the proven expertise of Eric, Ralf and Nigel and that they
will contribute significantly to the implementation of NextPharma's
Notes to Editors:
NextPharma, headquartered in the UK and founded in 2000, is a world
class outsourcing partner to the pharmaceutical and biotechnology
industry. The company:
Offers a full range of services from early phase product development,
through clinical trial packaging (Phases I through III), to high
volume commercial manufacturing. The company is a world leader in
modified release technologies and in specialist product manufacturing
including hormones, penicillins, and cephalosporins, in addition to
providing manufacturing and packaging services for conventional
product forms. Additionally, NextPharma offers integrated logistics
solutions tailored to meet the needs of the global pharmaceutical
Operates globally with six product development centres, six
manufacturing plants and six temperature controlled storage and
distribution sites across Europe (production facilities in France and
Germany), supplying customers in North America, Europe and the rest of
Has 1,000 employees dedicated to serving over 150 customers worldwide.
Its customer base includes many of the world's leading pharmaceutical,
specialty pharma and biotech companies.
[ Back To TMCnet.com's Homepage ]